Myra Ahmad keeps returning to a quiet failure in how patients are looked after. The information that should guide their care is scattered where no one can use it.
"Most providers are getting labs from separate systems that never talk to each other," the Mochi Health founder told Women of Wearables in April 2026.
For the patient, it means being treated by someone working with only part of the picture. Mochi's move to offer continuous glucose monitoring is aimed squarely at that gap.
Mochi says it is now making monitoring available to patients through its network of independent pharmacy partners. This means that the readings can feed the same provider relationship rather than vanishing into another disconnected app.
Care that is finally informed by the patient's own data
Ahmad has described building "toward giving patients and their providers access to lab testing that feeds directly into their care plan.”
This means that "labs, your medications, your provider relationship, and your care are all integrated in one system."
Glucose data fits naturally into that goal. Instead of a number a patient checks alone, monitoring becomes an input their provider can act on, the kind of individualized, responsive adjustment that distinguishes attentive care from a one-time prescription.
Mochi has built its reputation on continuity. Keeping patients with a provider who knows them over time. Glucose monitoring extends what the provider can actually see and do. The device is in service of the relationship.
"It's also going to be critical for labs and diagnostic data to become integrated directly into patient care," Ahmad told Women of Wearables, noting that today labs, medications, and the provider each sit in separate silos.
"Over the next five years, we're going to start connecting it all together and providing truly personalized care and medicine, rather than just talking about it."
Glucose monitoring is one early, tangible piece of that connecting work.
For a patient, the difference is concrete.
A reading that once sat unused in a separate app becomes something a provider can respond to, adjusting a plan toward what that individual's body actually needs rather than a one-size-fits-all default.
It also spares the patient from having to be their own care coordinator, tracking numbers no one else is watching.
It is the same personalization Ahmad has argued for across Mochi's care, applied to the daily data of metabolic health.
Why route it through independent pharmacies
The choice to deliver monitoring through independent pharmacies, rather than around them, reflects the same instinct to strengthen the people who deliver care.
In a January 2026 post, Mochi described building "a software-enabled marketplace that's making pharmacies better at what they do, which results in better patient outcomes," and reported growing its network from 10 to 33 pharmacies in a quarter, with more than 100 partners in view.
Patients can see each pharmacy's name, location, and turnaround time, and the company says it verifies partners and tests samples for purity and sterility.
Independent pharmacies, Mochi argues, are being squeezed as money is "extracted from the healthcare system" toward insurers, manufacturers, and pharmacy-benefit managers.
Giving those pharmacies a new product to offer, alongside modern software and patient volume, helps keep them viable. Adding glucose monitors to that network is meant to serve the patient and the neighborhood pharmacy at the same time.
Keep in Mind
The use of continuous glucose monitors outside of diagnosed diabetes is still an emerging area. The value depends entirely on whether a provider uses the data to change care rather than simply collecting it.
Folding device fulfillment into a growing pharmacy network adds operational complexity.
But the intent is consistent with everything Ahmad has said the company is for. She has spent years arguing that patients are failed when their care is fragmented and their data is siloed.
Putting glucose monitoring in patients' hands, connected to a provider who will actually use it and supplied through pharmacies, is a concrete attempt to close that gap.
Only time will tell if it improves patient. The reason behind it, though, is the same reason Mochi exists: because they care enough to give patients and their providers the full picture.
